Product Information

CLINDAMYCIN-BNZ PEROX 1-5% PMP is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.9215 per GM under NDC 45802050704. Its NADAC has been published 518 times since Sep 21, 2016.

FDA first approved this application on Sep 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLINDAMYCIN-BNZ PEROX 1-5% PMP

clindamycin and benzoyl peroxide
$0.9215per GM

NDC

45802050704

Classification

Generic

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202440

FDA Approved

9/21/2015

TE Code

AB

On Market Since

9/22/2015

Price Statistics

The NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has been published 518 times since Sep 21, 2016, and over the history we have for it it has declined 89.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9215 per GM
All-time high$8.4016 (Oct 12, 2016)
All-time low$0.4958 (Nov 20, 2024)
52-week high$1.0233
52-week low$0.8465
Median price$1.6434
Average price$2.7799
Largest weekly change+57.3% (Jan 17, 2024)
Weeks tracked518
Tracking sinceSep 21, 2016

Price History

1W

+3.7%

1M

+3.7%

3M

+0.7%

6M

+2.5%

1Y

-9.7%

3Y

-33.8%

5Y

-37.2%

All

-89.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of CLINDAMYCIN-BNZ PEROX 1-5% PMP?

The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BNZ PEROX 1-5% PMP, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.9215 per GM (NDC 45802050704), effective Aug 19, 2026.

How has the price of CLINDAMYCIN-BNZ PEROX 1-5% PMP changed over time?

Over the history we have for it, the NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has declined 89.0%. It has been tracked across 518 weekly CMS publications since Sep 21, 2016.

What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BNZ PEROX 1-5% PMP?

Since Sep 21, 2016, the NADAC for CLINDAMYCIN-BNZ PEROX 1-5% PMP has ranged from a low of $0.4958 (Nov 20, 2024) to a high of $8.4016 (Oct 12, 2016), with a median of $1.6434 per GM.

Are there cheaper alternatives to CLINDAMYCIN-BNZ PEROX 1-5% PMP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN-BENZOYL PEROX 1-5%, is $0.4661 per GM — about 49% below CLINDAMYCIN-BNZ PEROX 1-5% PMP.

Who manufactures CLINDAMYCIN-BNZ PEROX 1-5% PMP?

CLINDAMYCIN-BNZ PEROX 1-5% PMP (NDC 45802050704) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.